Escalating conflict in the Middle East is throttling global pharmaceutical supply chains, threatening generic drug availability and clinical trial progress.
Data shows a massive expansion of the US upper-middle class, yet financial anxiety remains high among top earners facing rising living costs.
Market volatility is creating undervalued opportunities in tech and value sectors as investors weigh AI spending concerns against historical Q2 trends.
New Google research shows quantum computing could break Bitcoin encryption faster than expected, raising urgent questions about blockchain security.
Dividend Aristocrats are outperforming the S&P 500 as investors shift into defensive utility and consumer staple stocks during economic volatility.
